-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Evolutionary Genomics, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2011 to Q1 2022.
- Evolutionary Genomics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2022 was -$176K, a 9.73% increase year-over-year.
- Evolutionary Genomics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$641K, a 59.5% increase from 2021.
- Evolutionary Genomics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$1.58M, a 31.1% increase from 2020.
- Evolutionary Genomics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$2.3M, a 267% decline from 2019.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)